Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome

被引:89
|
作者
Shang, Fu-Jun [1 ]
Wang, Jie-Pin [2 ]
Liu, Xiong-Tao [1 ]
Zheng, Qiang-Sun [1 ]
Xue, Yu-Sheng [1 ]
Wang, Bin [1 ]
Zhao, Lian-You [1 ]
机构
[1] Fourth Mil Med Univ, Dept Cardiol, Tangdu Hosp, Xian 710038, Shaanxi, Peoples R China
[2] Fourth Mil Med Univ, Dept Pharm, Tangdu Hosp, Xian 710038, Shaanxi, Peoples R China
关键词
Adipokines; biomarker; cardiometabolic syndrome; coronary atherosclerosis index; CHOLESTEROL; INFLAMMATION; ADIPOKINES; MORTALITY;
D O I
10.3109/1354750X.2011.622789
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Context: Omentin-1, an adipokine secreted from visceral adipose tissue, has been reported to be associated with coronary artery disease (CAD) and metabolic disorders. Objective: To clarify the relationship between serum omentin-1 levels and the presence and severity of CAD in patients with metabolic syndrome (MetS). Methods: We measured serum omentin-1 levels in 175 consecutive patients with MetS and in 46 controls. Results: Serum omentin-1 levels are inversely associated with the presence and angiographic severity of CAD in MetS patients. Conclusions: Serum omentin-1 might be a potential biomarker to predict the development and progression of CAD in MetS patients.
引用
收藏
页码:657 / 662
页数:6
相关论文
共 50 条
  • [21] Serum omentin-1 levels in hypertensive patients
    Mustafa Çelik
    Rukiye Nar
    Gökay Nar
    Erdoğan Sökmen
    Güven Günver
    Journal of Human Hypertension, 2021, 35 : 290 - 295
  • [22] Relationship between Atrial fibrillation and plasma omentin-1 levels in patients with coronary artery disease
    Nazar, Shazia
    Zehra, Sitwat
    RAWAL MEDICAL JOURNAL, 2020, 45 (04): : 762 - 765
  • [23] Serum osteocalcin levels are inversely associated with the presence of nonalcoholic fatty liver disease in patients with coronary artery disease
    Du, Jing
    Pan, Xiaoping
    Lu, Zhigang
    Gao, Meifang
    Hu, Xiang
    Zhang, Xueli
    Bao, Yuqian
    Jia, Weiping
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (11): : 21435 - 21441
  • [24] Serum osteocalcin levels are inversely associated with the presence of nonalcoholic fatty liver disease in patients with coronary artery disease
    Du, Jing
    Pan, Xiaoping
    Lu, Zhigang
    Gao, Meifang
    Hu, Xiang
    Zhang, Xueli
    Bao, Yuqian
    Jia, Weiping
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S138 - S138
  • [25] Impact of plasma adiponectin levels to the presence and severity of coronary artery disease in patients with metabolic syndrome
    Selcuk, Mehmet Timur
    Selcuk, Hatice
    Temizhan, Ahmet
    Maden, Orhan
    Saydam, Gul Sevim
    Dogan, Mehmet
    Ulupinar, Hakan
    Aydin, Cengiz
    Topcu, Deniz I.
    Sasmaz, Ali
    CORONARY ARTERY DISEASE, 2008, 19 (02) : 79 - 84
  • [26] Omentin-1, epicardial fat and coronary artery disease
    Klein, Cedric
    Ninni, Sandro
    Coisne, Augustin
    Staels, Bart
    Montaigne, David
    ATHEROSCLEROSIS, 2016, 255 : 224 - 225
  • [27] Decreased Levels of Serum Omentin-1 in Patients with Inflammatory Bowel Disease
    Yin, Jian
    Hou, Peng
    Wu, Zhiqiang
    Nie, Yanxiao
    MEDICAL SCIENCE MONITOR, 2015, 21 : 118 - 122
  • [28] The Association Between Serum Vaspin and Omentin-1 Levels in Obese Children with Metabolic Syndrome
    Buyukinan, Muammer
    Atar, Muge
    Can, Ummugulsum
    Pirgon, Ozgur
    Guzelant, Asuman
    Deniz, Isa
    METABOLIC SYNDROME AND RELATED DISORDERS, 2018, 16 (02) : 76 - 81
  • [29] Serum omentin is neither associated with the metabolic syndrome nor with angiographically determined coronary artery disease
    Saely, C. H.
    Muendlein, A.
    Vonbank, A.
    Geiger, K.
    Rein, P.
    Drexel, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 (15-16) : 568 - 568
  • [30] Serum Omentin is Neither Associated With the Metabolic Syndrome Nor With Angiographically Determined Coronary Artery Disease
    Vonbank, Alexander
    Saely, Christoph H.
    Muendlein, Axel
    Geiger, Kathrin
    Rein, Philipp
    Drexel, Heinz
    DIABETES, 2012, 61 : A717 - A717